Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gale

Showing results (241-250 of 359) with videos related to

Pageof 36
Sort By:
Mbio|May 3, 2018
Selective Packaging in Murine Coronavirus Promotes Virulence by Limiting Type I Interferon ResponsesJeremiah Athmer, Anthony R Fehr, Matthew E Grunewald, et al.
Nature Communications|August 24, 2018
Early cellular innate immune responses drive Zika viral persistence and tissue tropism in pigtail macaquesMegan A O'Connor, Jennifer Tisoncik-Go, Thomas B Lewis, et al.
Research Square|October 3, 2025
Host-microbe interactions characterized by gene expression of cervical adhesion molecules, cytokines, and growth factors define the recurrence of bacterial vaginosisNichole Klatt, Erik Swanson, Courtney Broedlow, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 16, 2017
Versican is produced by Trif- and type I interferon-dependent signaling in macrophages and contributes to fine control of innate immunity in lungsMary Y Chang, Inkyung Kang, Michael Gale, et al.
Genomics Data|November 16, 2016
Identifying protective host gene expression signatures within the spleen during West Nile virus infection in the collaborative cross modelRichard Green, Courtney Wilkins, Sunil Thomas, et al.
Journal of Virology|July 5, 2012
Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shockPenny A Rudd, Jane Wilson, Joy Gardner, et al.
Frontiers in Immunology|October 30, 2024
Functional genomic analysis of the 68-1 RhCMV-<i>Mycobacteria tuberculosis</i> vaccine reveals an IL-15 response signature that is conserved with vector attenuationCheng-Jung Sung, Leanne S Whitmore, Elise Smith, et al.
The Journal of Infectious Diseases|June 23, 2023
Rapid Antigen and Antibody Microfluidic Immunofluorescence Assays Compared to Culture, PCR, and Laboratory Reference Tests: Performance in a Longitudinal CohortRonit R Dalmat, Linhui Hao, Roshni Prabhu, et al.
Microbiology Spectrum|October 3, 2022
Combinations of Host- and Virus-Targeting Antiviral Drugs Confer Synergistic Suppression of SARS-CoV-2Jessica Wagoner, Shawn Herring, Tien-Ying Hsiang, et al.
Mbio|April 14, 2021
SARS-CoV-2 ORF6 Disrupts Bidirectional Nucleocytoplasmic Transport through Interactions with Rae1 and Nup98Amin Addetia, Nicole A P Lieberman, Quynh Phung, et al.
Pageof 36

Showing results (241-250 of 359) with videos related to

Sort By:
Pageof 36
Mbio|May 3, 2018
Selective Packaging in Murine Coronavirus Promotes Virulence by Limiting Type I Interferon ResponsesJeremiah Athmer, Anthony R Fehr, Matthew E Grunewald, et al.
Nature Communications|August 24, 2018
Early cellular innate immune responses drive Zika viral persistence and tissue tropism in pigtail macaquesMegan A O'Connor, Jennifer Tisoncik-Go, Thomas B Lewis, et al.
Research Square|October 3, 2025
Host-microbe interactions characterized by gene expression of cervical adhesion molecules, cytokines, and growth factors define the recurrence of bacterial vaginosisNichole Klatt, Erik Swanson, Courtney Broedlow, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|September 16, 2017
Versican is produced by Trif- and type I interferon-dependent signaling in macrophages and contributes to fine control of innate immunity in lungsMary Y Chang, Inkyung Kang, Michael Gale, et al.
Genomics Data|November 16, 2016
Identifying protective host gene expression signatures within the spleen during West Nile virus infection in the collaborative cross modelRichard Green, Courtney Wilkins, Sunil Thomas, et al.
Journal of Virology|July 5, 2012
Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shockPenny A Rudd, Jane Wilson, Joy Gardner, et al.
Frontiers in Immunology|October 30, 2024
Functional genomic analysis of the 68-1 RhCMV-<i>Mycobacteria tuberculosis</i> vaccine reveals an IL-15 response signature that is conserved with vector attenuationCheng-Jung Sung, Leanne S Whitmore, Elise Smith, et al.
The Journal of Infectious Diseases|June 23, 2023
Rapid Antigen and Antibody Microfluidic Immunofluorescence Assays Compared to Culture, PCR, and Laboratory Reference Tests: Performance in a Longitudinal CohortRonit R Dalmat, Linhui Hao, Roshni Prabhu, et al.
Microbiology Spectrum|October 3, 2022
Combinations of Host- and Virus-Targeting Antiviral Drugs Confer Synergistic Suppression of SARS-CoV-2Jessica Wagoner, Shawn Herring, Tien-Ying Hsiang, et al.
Mbio|April 14, 2021
SARS-CoV-2 ORF6 Disrupts Bidirectional Nucleocytoplasmic Transport through Interactions with Rae1 and Nup98Amin Addetia, Nicole A P Lieberman, Quynh Phung, et al.
Pageof 36